Compugen Ltd logo

Compugen Ltd

1
NAS:CGEN (Israel)  
$ 2.57 +0.04 (+1.57%) 11:08 PM EST
At Loss
P/B:
3.44
Market Cap:
$ 228.22M
Enterprise V:
$ 174.52M
Volume:
281.36K
Avg Vol (2M):
665.59K
Also Trade In:
Volume:
281.36K
At Loss
Avg Vol (2M):
665.59K

Business Description

Description
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902, bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
Name Current Vs Industry Vs History
Cash-To-Debt 37.51
Equity-to-Asset 0.54
Debt-to-Equity 0.02
Debt-to-EBITDA -0.1
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.19
Distress
Grey
Safe
Beneish M-Score 39.98
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 44.46
9-Day RSI 46.83
14-Day RSI 50.35
6-1 Month Momentum % 192.05
12-1 Month Momentum % 256.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.36
Quick Ratio 4.36
Cash Ratio 1.93
Days Sales Outstanding 665.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.2
Shareholder Yield % 0.27

Financials (Next Earnings Date:2024-05-15 Est.)

CGEN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CGEN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Compugen Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 33.459
EPS (TTM) ($) -0.21
Beta 3.02
Volatility % 212.83
14-Day RSI 50.35
14-Day ATR ($) 0.173994
20-Day SMA ($) 2.674
12-1 Month Momentum % 256.3
52-Week Range ($) 0.53 - 3.0301
Shares Outstanding (Mil) 89.53

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Compugen Ltd Filings

Filing Date Document Date Form
No Filing Data

Compugen Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Compugen Ltd Frequently Asked Questions

What is Compugen Ltd(CGEN)'s stock price today?
The current price of CGEN is $2.57. The 52 week high of CGEN is $3.03 and 52 week low is $0.53.
When is next earnings date of Compugen Ltd(CGEN)?
The next earnings date of Compugen Ltd(CGEN) is 2024-05-15 Est..
Does Compugen Ltd(CGEN) pay dividends? If so, how much?
Compugen Ltd(CGEN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1